脉冲电磁场辅助治疗对原发性骨质疏松症的疗效观察

The effect of pulsed electromagnetic fields (PEMF) on management of osteoporosis

目的观察脉冲电磁场结合钙剂和维生素D治疗对原发性骨质疏松症患者骨痛、日常活动能力和骨密度等的影响。方法收集原发性骨质疏松症患者120例，其中，男性50例，女性70例。年龄50～90岁，平均（68±15）岁。随机分为两组，其中治疗组66例，对照组54例。治疗组采用BGl00-A型骨质疏松治疗系统联合维生素D和钙剂口服，对照组采用单纯钙剂和维生素D口服，连续治疗至少60d。治疗前后分别测定患者VAS疼痛评分、ADL日常生活活动评分和骨密度。结果①治疗组VAS评分在治疗后1月即开始下降，治疗后2月VAS评分进一步下降，与对照组相比均有显著性差异（P〈0．01）；②治疗后1月治疗组ADL评分升高，治疗后2月ADL评分进一步上升，与对照组相比均有显著性差异（P〈0．01）；③治疗后1月治疗组骨密度即升高7．9％，治疗后2月治疗组骨密度进一步升高，与对照组相比差异显著（P〈0．05）。结论脉冲电磁场可显著提高骨密度，缓解原发性骨质疏松症的临床骨痛，并能够明显改善患者的日常生活活动能力。

Objective To observe and evaluate the effect of pulsed electromagnetic fields （PEMF） with Vitamin D and calcium on bone pain, activity of daily living and bone mineral density （BMD） of osteoporosis. Methods 120 patients with primary osteoporosis were elected, including 50 male and 70 female, the average age was 68 ± 15 years old （50 to 90 years old）. All patients were divided into two groups, the treatment group （66 patients） and the control group （54 patients）. The treatment group received therapy of BGIOO-A osteoporosis treatment system. Both of the treatment and control group were given caltrate-D （including calcium and Vitamin D3 ） for 60 days. Visual analogue score （VAS）, activity of daliy living（ADL） scale and BMD were determined before and after the course. Finally, the two groups were compared statistically. Results ①The VAS of two groups had no significant difference before the therapy, but that of treatment group significantly declined 1 month later, and further down 2 months later, compared to the control group （P 〈 0.01 ）. ②The ADL of two groups had no significant difference before the therapy, but that of treatment group significantly increased 1 month later, and further up 2 months later, compared to the control group（ P 〈 0.05）. ③The BMD of two groups had no significant difference before the therapy, but that of treatment group increased 7.9% one month later, and significantly up 2 months later, compared to the control group （ P 〈 0.01 ）. Conclusions PEMF can significantly improve bone ache, activity of daily living and BMD of osteoporosis.